This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
The FDA’s current draft guidance on the approval process for AI devices does not specify the type of validation the agency recommends manufacturers use.
Beginning September 10, breast imaging facilities will be required to notify patients about the density of their breasts, among other regulatory changes.
Amidst rising cancer prevalence and soaring costs, new cancer technologies and innovations are emerging to support the early detection, treatment, and surveillance of cancer. Read this guide to understand how to evaluate these solutions for your employees and members – and to learn more about the current state of coverage, clinical and cost effectiveness, and impact on quality and outcomes.
Using digital breast tomosynthesis (DBT) and supplemental MRI yields more benefits but also confers more risks, according to simulation data published August 26 in JAMA Internal Medicine. Researchers led by Natasha Stout, PhD, from Harvard Medical School in Boston, MA, found that while DBT plus supplemental breast MRI leads to more deaths averted, it also leads to more false-positive recalls and false-positive biopsy recommendations for women of most breast density categories.
Despite amassing a wait list of 10,000 individuals, the company has confronted “significant barriers due to restrictions on private imaging services in Ontario.
Despite amassing a wait list of 10,000 individuals, the company has confronted “significant barriers due to restrictions on private imaging services in Ontario.
“Living” and “viable” should be avoided in first-trimester ultrasound lexicon when imaging pregnant women, according to new guidelines introduced August 27 by the Society of Radiologists in Ultrasound (SRU), published in Radiology. In what the RSNA is calling a first, the lexicon developed by a multisociety panel addresses terms frequently used in first-trimester ultrasound reports, such as “ectopic pregnancy,” “heartbeat,” “living,” and “viable.
Private equity-backed groups such as Rad Partners have dominated IDR use, with "little evidence" rank-and-file radiologists are using the system, experts wrote in Health Affairs.
Increased perivascular space volume (PVS) in the brains of former football players appears to be associated with repetitive head impacts (RHI), cognitive impairment, and the development of neurodegeneration, researchers have found. A team led by Leonard Jung, MD, of Brigham and Women's Hospital in Boston, reported that these athletes had larger PVS volume compared with the unexposed group -- a finding that was associated with poor cognitive performance.
Patient-centric scheduling can only be achieved through optimized radiology workflows, effective communications between staff and physicians, and, of course, through specialized schedulers. In this guide, we’ll take you through a step-by-step process to transform your radiology center into a high-performance hub of medical imaging.
An ultrasound-based deep learning radiomics nomogram (DLRN) model performed well in a study about predicting tumor status and lymph node metastasis in breast cancer patients post chemotherapy. The study, published in Academic Radiology on August 24, found that the DLRN model demonstrated high receiving operator curve (ROC) values, as well as moderate consistency in this area, according to researchers led by Sheng-Chun Shu, PhD, from the Second Affiliated Hospital of Guangzhou University of Chine
We use the word 'love' in a bewildering range of contexts -- from sexual adoration to parental love or the love of nature. Now, more comprehensive imaging of the brain may shed light on why we use the same word for such a diverse collection of human experiences.
An Australian radiologist fired after a colleague claimed he "performed a pelvic thrust" at her at a Christmas party has been awarded more than 350,000 Australian dollars ($237,000 U.S.) in damages, according to a report posted on news.com.au. Kevin Daynes, MD, filed suit with the New South Wales Supreme Court after he was fired in May 2022 from the I-MED Radiology Cairns clinic for "bullying conduct and victimization" complaints from a female radiographer and a sexual harassment complaint from
About 40% of us will be diagnosed with cancer in our lifetime, and patients are getting younger. At the same time, the cost of treatment continues to rise, with employers spending 8.5% more on cancer care for each employee than they did last year. The best thing employers can do for their employees and business tomorrow is to invest in cancer detection and care today.
Commercial AI devices that lack adequate clinical validation may pose risks for patient care – and unfortunately, that’s true for almost half of the tools cleared so far by the U.S. Food and Drug Administration (FDA), says a group at the University of North Carolina in Chapel Hill. In an August 26 commentary in Nature Medicine , the group discussed an analysis they performed of AI device clearances to date and called on the FDA and AI developers to publish more clinical validation data and prior
With her large experience in the pharmaceutical industry, Helen Blanco currently serves as Chief Operating Officer at Node Pharma , a preclinical radiopharmaceutical company based in Norway. We recently spoke with Helen about the key criteria when selecting an imaging vendor and exciting upcoming innovations in the oncology space. The following is the first excerpt from our conversation.
Editor's note: As part of the celebration of AuntMinnie.com's upcoming 25th anniversary, we're presenting 25 for 25 -- a series featuring our most popular content for each of the last 25 years. New articles will be published each Monday until our official anniversary at RSNA 2024. Our top article in 2010 was a follow-up of our most highly viewed article in 2009.
Discover how Color's comprehensive care solution is revolutionizing cancer screening adherence and knowledge. Through an in-depth case study, Color's unique approach to comprehensive cancer care has shown significant benefits in increasing screening rates and enhancing patient knowledge. Participants reported a 2-3x increase in adherence to screening guidelines over just 8 weeks, with 84% of participants increasing their familiarity with timing and frequency of cancer screening.
Madison, WI-based radiotherapy firm Accuray has received marketing clearance in Europe for its new helical radiation delivery system, Accuray Helix. The CT-guided system is designed to deliver targeted radiation to treat breast, cervix, head and neck, gastrointestinal, lung, and prostate cancer. Accuray Helix is intended for emerging markets where patient access to care with radiotherapy is challenged and where versatility and ease of use are a high priority.
Our jargon and shorthand in radiology continue to evolve as we strive for efficiency in balancing terminology shifts, medicolegal considerations, voice recognition hurdles, and other demands of our field.
The benefits of endovascular thrombectomy in patients with acute basilar artery occlusion are sustained at long-term follow-up, according to a study published August 26 in JAMA Neurology. In an analysis of outcomes of a large clinical trial, researchers found that “excellent” outcomes increased between 90 days and one year in patients who underwent the procedure, but not in patients who received only intravenous thrombolytics, antiplatelet drugs, or anticoagulants (the three of which currently r
Magnetic resonance imaging (MRI) revolutionized medical diagnostics by evolving from nuclear magnetic resonance discoveries to life-saving technology. The post A Short History of Magnetic Resonance Imaging (MRI) appeared first on Open MedScience.
Explore the latest insights from the American Cancer Society's “Cancer Statistics 2024” report, which unveils multiple alarming trends in cancer data. Cancer is on the rise among young adults, and diagnoses for 6 of the 10 most common cancers are escalating. With over 2 million new cancer cases projected in the U.S. this year, employers face increased challenges when it comes to supporting employees.
GE HealthCare (GEHC) has secured the CE Mark for both its wireless handheld ultrasound system, Vscan Air SL, and its electrocardiogram (ECG)-less cardiac CT Revolution Apex Elite platform. Vscan Air SL wireless features the company's Caption AI, an AI-driven software for cardiac assessments at the point of care, according to the firm. Once a user captures an image, Vscan Air SL's AutoEF (ejection fraction) feature automatically calculates a left ventricular ejection fraction, which is a key meas
With her large experience in the pharmaceutical industry, Helen Blanco currently serves as Chief Operating Officer at Node Pharma , a preclinical radiopharmaceutical company based in Norway. We recently interviewed Helen about managing a multicultural team and the Scandinavian market - discussing the challenges, strengths, and promising future. Here is another excerpt from our conversation.
Siemens Healthineers has offered Novartis more than 200 million euros ($224 million U.S.) for the diagnostic arm of its Advanced Accelerator Applications molecular imaging business for F-18 fluciclovine PET exams, Reuters has reported. Novartis bought Advanced Accelerator Applications for $3.9 billion in 2017, according to Reuters. The Siemens/Novartis deal will close in the fourth quarter, the outlet said.
A sophisticated platform uses histotripsy to deliver precision-targeted, pulsed sound energy into the body without any incisions or needles, destroying.
As HR and Benefits leaders are in the midst of evaluating cancer care solutions and designing their requirements for vendors, it’s key to know what questions to ask to ensure the development of a truly comprehensive strategy: from prevention to diagnosis to treatment to survivorship. Getting to the right answers starts with asking the right questions: How can better access improve engagement?
Input your email to sign up, or if you already have an account, log in here!
Enter your email address to reset your password. A temporary password will be e‑mailed to you.
We organize all of the trending information in your field so you don't have to. Join 5,000 users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content